doi:10.1007/s11154-021-09699-1 45
These figures underscore a critical disconnect between clinical access, real-world adherence, and treatment outcomes with payer friction playing a central role
Other reported effects of the peptide include vivid dreams, improved alertness during the day, and better performance during high-intensity interval training, possibly due to its modulation of various pathways, including PPR alpha and PPR gamma 8m0s
The FDA decided on October 2, 2024, that the tirzepatide shortage was over, and doubled down on that in December 2024
There is no clinical justification for self-administering an unapproved, bulk-sourced compound when safe, effective, and regulated alternatives exist
The FDA has identified serious adverse events associated with CJC-1295, including increased heart rate and systemic vasodilatory reaction